AXGN

#2050
Axogen, Inc. Common Stock
34.2800 USD
+2.42%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
34.0900
34.4200
Year Range
17.1400
35.9999
Daily Change
+2.42%
Monthly Change
+4.48%
6 month change
+87.94%
Year Change
+87.94%
Previous Close
33.4700
Open
34.4200
Bid
Ask
Low
34.0900
High
34.4200
Volume
50
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
  • Market Capitalization 1.7791 B
  • Employee 622
  • Founded 2002
  • CEO N/A
  • Website www.axogeninc.com
  • Headquarter Minnesota, United States
  • FIGI BBG000BN46R9
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-96.26
Price to sales ratio
6.69

Axogen Inc

Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator. As of 2019, Axogen was the only commercially available allograft approved by the Food and Drug Administration for clinical use.

News